Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy

Imatinib has so far been the first-choice treatment in chronic myeloid leukemia with excellent results. However, only a proportion of patients achieve major molecular response – hence the need to find biological predictors of outcome to select the optimal therapeutic strategy now that more potent in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Angelini, Sabrina, Soverini, Simona, Ravegnini, Gloria, Barnett, Matt, Turrini, Eleonora, Thornquist, Mark, Pane, Fabrizio, Hughes, Timothy P., White, Deborah L., Radich, Jerald, Kim, Dong Wook, Saglio, Giuseppe, Cilloni, Daniela, Iacobucci, Ilaria, Perini, Giovanni, Woodman, Richard, Cantelli-Forti, Giorgio, Baccarani, Michele, Hrelia, Patrizia, Martinelli, Giovanni
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2013
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3561425/
https://ncbi.nlm.nih.gov/pubmed/22875622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.066480
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados